Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benbadis, S. R.
Right arrow Articles by Vale, a. F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benbadis, S. R.
Right arrow Articles by Vale, a. F. L.
Neurology 2000;55:1780-1784
© 2000 American Academy of Neurology


Views & Reviews

When drugs don’t work

An algorithmic approach to medically intractable epilepsy

Selim R. Benbadis, MD;, William O. Tatum, IV, DO; and and Fernando L. Vale, MD

From the Comprehensive Epilepsy Program, Departments of Neurology (Drs. Benbadis and Tatum) and Neurological Surgery (Drs. Benbadis and Vale), University of South Florida College of Medicine and Tampa General Healthcare.

Address correspondence and reprint requests to Dr. Selim R. Benbadis, Associate Professor, Departments of Neurology & Neurosurgery, University of South Florida College of Medicine, 4 Columbia Drive, Suite 730, Tampa, FL 33606; e-mail: sbenbadi{at}hsc.usf.edu

Article abstract—Nonpharmacologic options for the treatment of epilepsy include epilepsy surgery, vagus nerve stimulation, and the ketogenic diet. The advantages and limitations of these treatment modalities have been extensively reviewed, but there is no general consensus on when each option should be considered. The authors propose an algorithm based on the type of epilepsy. Generally, nonpharmacologic options should be considered early—i.e., after the first few drug failures. Because of their good outcome with resective surgery, mesial temporal and lesional neocortical epilepsies should be considered for resection. Conversely, nonlesional neocortical epilepsies are probably best approached with vagus nerve stimulation first. For symptomatic or cryptogenic generalized epilepsies, which are commonly intractable, vagus nerve stimulation and the ketogenic diet appear to be reasonable options to consider before palliative surgery such as corpus callosotomy. Idiopathic (i.e., genetic) generalized epilepsies are only rarely refractory to medications and can be outgrown. In rare cases, vagus nerve stimulation may occasionally play a role in their treatment.




This article has been cited by other articles:


Home page
J Child NeurolHome page
C.-C. Chen, P.-C. Chiu, and M.-T. Chen
Reinvestigation and Reduction of Polytherapy in Children With Chronic Seizures
J Child Neurol, January 1, 2007; 22(1): 15 - 20.
[Abstract] [PDF]


Home page
J. Neurophysiol.Home page
M. M. Haglund and D. W. Hochman
Furosemide and Mannitol Suppression of Epileptic Activity in the Human Brain
J Neurophysiol, August 1, 2005; 94(2): 907 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R Wennberg
Short term benefit of battery depletion in vagus nerve stimulation for epilepsy
J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 939 - 939.
[Full Text]


Home page
NeurologyHome page
J. B. Renfroe and J. W. Wheless
Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy
Neurology, September 24, 2002; 59(90064): S26 - 30.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.